001     141073
005     20210129212839.0
024 7 _ |a 10.1039/c3mt00143a
|2 doi
024 7 _ |a 1756-5901
|2 ISSN
024 7 _ |a 1756-591X
|2 ISSN
024 7 _ |a WOS:000327461800012
|2 WOS
037 _ _ |a FZJ-2013-06275
082 _ _ |a 690
100 1 _ |a Nischwitz, Volker
|0 P:(DE-Juel1)157638
|b 0
|e Corresponding author
245 _ _ |a Speciation studies of vanadium in human liver (HepG2) cells after in vitro exposure to bis(maltolato)oxovanadium(iv) using HPLC online with elemental and molecular mass spectrometry
260 _ _ |a Cambridge
|c 2013
|b RSC Publ.
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1386929386_12841
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
500 _ _ |3 POF3_Assignment on 2016-02-29
536 _ _ |a 351 - Mechanisms of Response: Cellular Mechanisms in Disease Development and Therapy (POF2-351)
|0 G:(DE-HGF)POF2-351
|c POF2-351
|x 0
|f POF II
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Davies, Julie T.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Marshall, Damian
|0 P:(DE-HGF)0
|b 2
700 1 _ |a González, Macarena
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Gómez Ariza, Jose Luis
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Goenaga-Infante, Heidi
|0 P:(DE-HGF)0
|b 5
773 _ _ |a 10.1039/c3mt00143a
|g Vol. 5, no. 12, p. 1685 -
|p 1685 -
|n 12
|0 PERI:(DE-600)2474317-3
|t Metallomics
|v 5
|y 2013
|x 1756-591X
856 4 _ |u https://juser.fz-juelich.de/record/141073/files/FZJ-2013-06275.pdf
|z Published final document.
|y Restricted
909 C O |o oai:juser.fz-juelich.de:141073
|p VDB
910 1 _ |a Analytik
|0 I:(DE-Juel1)ZEA-3-20090406
|k ZEA-3
|b 0
|6 P:(DE-Juel1)157638
913 2 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF3-890
|0 G:(DE-HGF)POF3-899H
|2 G:(DE-HGF)POF3-800
|v Addenda
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Umweltbedingte Störungen der Gesundheit
|1 G:(DE-HGF)POF2-350
|0 G:(DE-HGF)POF2-351
|2 G:(DE-HGF)POF2-300
|v Mechanisms of Response: Cellular Mechanisms in Disease Development and Therapy
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
914 1 _ |y 2013
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 1 _ |0 I:(DE-Juel1)ZEA-3-20090406
|k ZEA-3
|l Analytik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ZEA-3-20090406


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21